Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells
- 30 January 1995
- journal article
- Published by Wiley in FEBS Letters
- Vol. 358 (3) , 311-315
- https://doi.org/10.1016/0014-5793(94)01458-d
Abstract
Vascular endothelial growth factor (VEGF) mRNA expression was analysed in rabbit vascular smooth muscle cells following exposure to hypoxia and platelet-derived growth factor-BB (PDGF-BB). Hypoxia potently upregulated VEGF mRNA steady-state levels in a time- and concentration-dependent manner reaching a maximum level (approximately 30-fold increase) after 12-24 h at 0% 0(2). In contrast, PDGF-BB caused a modest increase in VEGF expression. However, the combination of PDGF-BB and a threshold hypoxic stimulus (2.5% O2 for 4 h) had a marked synergistic effect. Synergy between hypoxia and PDGF-BB was selective for VEGF expression as hypoxia had no effect on the PDGF-induced upregulation of the proto-oncogene c-myc. These results raise the possibility that hypoxia and PDGF-BB may act in concert to induce VEGF expression in the arterial wall during the development of atherosclerosis.Keywords
This publication has 22 references indexed in Scilit:
- Hypoxia Is a Strong Inducer of Vascular Endothelial Growth Factor mRNA Expression in the HeartBiochemical and Biophysical Research Communications, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992
- Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of ProteinsEndocrine Reviews, 1992
- Arterial wall oxygenation, oxyradicals, and atherosclerosisAtherosclerosis, 1991
- Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosisEuropean Journal of Clinical Investigation, 1991
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.The Journal of Experimental Medicine, 1990
- Human Vascular Permeability FactorPublished by Elsevier ,1989
- Nature of Species Differences in the Medial Distribution of Aortic Vasa Vasorum in MammalsCirculation Research, 1967